Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

citrate liver fibrosis metabolic dysfunction-associated steatotic liver disease nuclear magnetic resonance spectroscopy tricarboxylic acid cycle metabolites

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Aug 2023
Historique:
received: 01 08 2023
revised: 21 08 2023
accepted: 24 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is associated with mitochondrial damage. Circulating mitochondrial metabolites may be elevated in NAFLD but their associations with liver damage is not known. This study aimed to assess the association of key mitochondrial metabolites with the degree of liver fibrosis in the context of NAFLD and nonalcoholic steatohepatitis (NASH). Cross-sectional analyses were performed on two cohorts of biopsy-proven NAFLD and/or NASH subjects. The association of circulating mitochondrial metabolite concentrations with liver fibrosis was assessed using linear regression analysis. In the single-center cohort of NAFLD subjects (n = 187), the mean age was 54.9 ±13.0 years, 40.1% were female and 86.1% were White. Type 2 diabetes (51.3%), hypertension (43.9%) and obesity (72.2%) were prevalent. Those with high citrate had a higher proportion of moderate/significant liver fibrosis (stage F ≥ 2) (68.4 vs. 39.6%,

Identifiants

pubmed: 37686138
pii: ijms241713332
doi: 10.3390/ijms241713332
pmc: PMC10487511
pii:
doi:

Substances chimiques

Citric Acid 2968PHW8QP
Citrates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : K08 DK115883
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA030770
Pays : United States

Références

Mol Genet Metab. 2003 Nov;80(3):356-9
pubmed: 14680984
Cell Mol Gastroenterol Hepatol. 2021;11(2):389-406
pubmed: 32942044
Hepatology. 2013 Oct;58(4):1497-507
pubmed: 23299992
Hepatology. 2011 Mar;53(3):810-20
pubmed: 21319198
Antioxidants (Basel). 2023 May 08;12(5):
pubmed: 37237931
J Biol Chem. 2012 Nov 23;287(48):40732-44
pubmed: 23035112
Lancet. 2018 Mar 24;391(10126):1174-1185
pubmed: 29519502
Liver Int. 2020 Sep;40(9):2148-2159
pubmed: 32558346
Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94
pubmed: 26814015
J Mol Cell Cardiol. 2004 Nov;37(5):921-9
pubmed: 15522269
Cell Metab. 2011 Dec 7;14(6):804-10
pubmed: 22152305
Proc Natl Acad Sci U S A. 1981 May;78(5):2861-3
pubmed: 6265919
PLoS Med. 2014 Feb 25;11(2):e1001606
pubmed: 24586121
Biol Chem. 2014 Apr;395(4):387-99
pubmed: 24445237
Mayo Clin Proc. 1980 Jul;55(7):434-8
pubmed: 7382552
FEBS Lett. 2013 Aug 2;587(15):2461-6
pubmed: 23792160
Adv Biol (Weinh). 2023 Jul;7(7):e2300095
pubmed: 37132059
Int J Mol Sci. 2021 Jun 19;22(12):
pubmed: 34205414
Pract Lab Med. 2021 Mar 18;25:e00213
pubmed: 33869707
Gastroenterology. 2001 Apr;120(5):1183-92
pubmed: 11266382
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Obesity (Silver Spring). 2008 May;16(5):958-64
pubmed: 18277391
Hepatology. 2017 May;65(5):1557-1565
pubmed: 28130788
Nutr Clin Pract. 2011 Oct;26(5):565-76
pubmed: 21947639
Hepatology. 2019 Oct;70(4):1457-1469
pubmed: 30924946
Nutrients. 2019 Mar 26;11(3):
pubmed: 30917546
J Hepatol. 2016 Dec;65(6):1245-1257
pubmed: 27486010
Hepatology. 2021 May;73(5):2028-2038
pubmed: 33111374
Liver Int. 2016 Aug;36(8):1213-20
pubmed: 26815314
Clin Endocrinol (Oxf). 2008 Mar;68(3):375-81
pubmed: 17877759
Lancet Healthy Longev. 2023 Feb;4(2):e72-e82
pubmed: 36738747
J Hepatol. 2020 Jul;73(1):202-209
pubmed: 32278004
Gastroenterology. 2020 May;158(6):1611-1625.e12
pubmed: 32027911
HSOA J Hum Endocrinol. 2016;1(1):
pubmed: 28286881
Hepatology. 2010 Jan;51(1):307-28
pubmed: 20034030
J Hepatol. 2008 Nov;49(5):810-20
pubmed: 18620775
Ann Hepatol. 2023 Jun 20;:101133
pubmed: 37364816
Diabetes Care. 2011 Jun;34(6):e61-99
pubmed: 21617108
PLoS One. 2020 Feb 21;15(2):e0228710
pubmed: 32084168
Cell Metab. 2019 Apr 2;29(4):932-949.e4
pubmed: 30639359
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
J Clin Med. 2020 Jan 23;9(2):
pubmed: 31979327
Nat Rev Mol Cell Biol. 2008 Mar;9(3):193-205
pubmed: 18200017
Gastroenterology. 2018 Sep;155(3):629-647
pubmed: 30012333
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Biosensors (Basel). 2011 Jul 12;1(3):107-17
pubmed: 25586923
Cell Syst. 2018 Jan 24;6(1):103-115.e7
pubmed: 29361464
Cell Death Differ. 2020 Jul;27(7):2143-2157
pubmed: 31959914

Auteurs

Waseem Amjad (W)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Boston, MA 02215, USA.

Irina Shalaurova (I)

Labcorp, Morrisville, NC 27560, USA.

Erwin Garcia (E)

Labcorp, Morrisville, NC 27560, USA.

Eke G Gruppen (EG)

Divisions of Nephrology and Endocrinology, University Medical Center Groningen (UMCG), University of Groningen, 9713 Groningen, The Netherlands.

Robin P F Dullaart (RPF)

Divisions of Nephrology and Endocrinology, University Medical Center Groningen (UMCG), University of Groningen, 9713 Groningen, The Netherlands.

Alex M DePaoli (AM)

NGM Bio, South San Francisco, CA 94080, USA.

Z Gordon Jiang (ZG)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Boston, MA 02215, USA.

Michelle Lai (M)

Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Boston, MA 02215, USA.

Margery A Connelly (MA)

Labcorp, Morrisville, NC 27560, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH